Bristol-Myers Squibb expands cancer research facilities in Redwood City
REDWOOD CITY, Calif. — Bristol-Myers Squibb has signed on for additional space in Redwood City to continue its cancer treatment research.
Visit the company’s Careers page here.
The new lab and office space will be a state-of-the-art research facility, including well thought-out research and material flows, security controls, collaboration spaces, safety considerations and interactive lab and office arrangements.
In addition, the new facility is being built not only to support scientific innovation, but also to set a new standard in energy and water efficiency. In fact, the Redwood City office is the first Bristol-Myers Squibb site to undertake the “Energy Star Challenge for Industry” – a program that requires a 10 percent reduction in energy usage over the next five years.
The 62,000-square-foot expansion adds a third building to Bristol-Myers Squibb’s existing 194,000 square feet at the company’s Bay Area hub for discovering pioneering cancer therapies in the innovative field of immuno-oncology, including novel biologics therapeutics.
With this latest agreement, Bristol-Myers Squibb will lease the entire Woodside Technology Park property which is comprised of approximately 256,000 square feet of real estate in the heart of the Bay Area Peninsula’s life science and high-tech communities. The term of the leases for all three buildings now extends through March 2027.
“The expansion of our facilities in Redwood City is evidence of the value that Bristol-Myers Squibb sees in the Bay Area scientific community and our relationship with BioMed Realty,” said Nils Lonberg, Head of Oncology Biology Discovery at Bristol-Myers Squibb.
Images courtesy of Bristol-Myers Squibb